News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Barry Ritholtz, Noted Stock Market Analyst, Appointed to the Board of Directors of MicroIslet Inc.
September 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO, Sept. 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Barry Ritholtz has been named to the Company's Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Autoimmune disease
Cullinan Bets $700M+ in Back-Heavy China Deal for Autoimmune T Cell Engager
June 5, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Rapt Shrinks Again After Dumping Asthma, Atopic Dermatitis Drug
June 5, 2025
·
219 min read
·
BioSpace Editorial Staff
Obesity
Lilly Inks Deal Worth up to $870M To Develop Long-Acting GLP-1 Obesity Drugs
June 4, 2025
·
2 min read
·
Nick Paul Taylor
Business
Opinion: Investing in Research and Welcoming Global Talent Strengthens America
June 4, 2025
·
4 min read
·
Dr. Chris Otiko
